moannana

$AXSM on POSSIBLE PLUMMETS

NASDAQ:AXSM   Axsome Therapeutics, Inc
AXSM clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system, it is accelerating the completion of the ADVANCE-1 Phase 2/3 trial of AXS-05 in patients with Alzheimer’s disease agitation to ensure the safety of this vulnerable patient population during the COVID-19 pandemic. i expect that this end of the month its increasing thoroughly. Are you guys ready to get through resistance? why not?

Comments

in at 62 out at 98.05 back in at 87.00 maybe abit early today.
+1 Reply